Finance

Lists
Why is KOD up 3.49%?
Dive Deeper
KOD:NASDAQ
Kodiak Sciences Inc
$94.26
+3.49%
(+3.18) 1D
$94.39
+0.13% (+0.13)
After hours
Closed: Oct 8, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KOD...
Open
$90.01
High
$94.95
Low
$89.54
Mkt. cap
5.92B
Avg. vol.
2.66M
Volume
0.00
52-wk high
$104.00
52-wk low
$10.94
EPS
-$4.19
Beta
2.03
Shares outstanding
62.85M
No. of employees
141
Open
$90.01
High
$94.95
Low
$89.54
Mkt. cap
5.92B
Avg. vol.
2.66M
Volume
0.00
52-wk high
$104.00
52-wk low
$10.94
EPS
-$4.19
Beta
2.03
Shares outstanding
62.85M
No. of employees
141
News stories
From web sources and news partners
About Kodiak Sciences Inc
CEO-
Employees141
Founded2005
HeadquartersPalo Alto, California, United States
SectorCapital market
Websitekodiak.com
Analyst ratings
Based on 7 analysts giving stock ratings to KOD in the past 3 months
Strong buy
Buy
6
Hold
1
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for KOD in the last 3 months.
Highest
Current $94.26
$145.00 (+53.83%)
Average
$115.20 (+22.22%)
Lowest
$96.00 (+1.85%)
Analyst
Recommendation
Action
Price target
Projected
Date
Maury Raycroft
Jefferies
Buy
Maintained
$112.00
+18.8%
10/05/2026
Andrea Newkirk
Goldman Sachs
Hold
Maintained
$103.00
+9.3%
09/29/2026
Anupam Rama
J.P. Morgan
Buy
Maintained
-
-
09/28/2026
Michael Yee
UBS
Buy
Reiterated
$120.00
+27.3%
09/28/2026
Matthew Caufield
H.C. Wainwright
Buy
Reiterated
$96.00
+1.8%
09/29/2026
Umer Raffat
Evercore ISI
Buy
Maintained
-
-
09/28/2026
Patrick Dolezal
LifeSci Capital
Buy
Maintained
$145.00
+53.8%
09/28/2026
Unknown Analyst
Goldman Sachs
Hold
Initiated
-
-
09/24/2026
Daniil Gataulin
Chardan Capital
Buy
Upgraded
$61.00
-35.3%
05/11/2026
Previous reports
Loading Previous Earnings...
Revenue
Net income
Revenue
Cost of goods sold
Cost of revenue
Research and development expenses
Total research and development expenses
Selling, general, and admin expenses
Operating expense
Total operating expenses
Operating income
Other non operating income
EBT including unusual items
EBT excluding unusual items
Income tax expense
Effective tax rate
Other operating expenses
Net income
Net profit margin
Earnings per share
Interest and investment income
Interest expense
Net interest expenses
Depreciation and amortization charges
EBITDA
Gain or loss from assets sale
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps